[Induction of cytotoxic activity in sera by immunomodulators].
D000818:Animals; D001688:Biological Products / Q000494:pharmacology*; D003208:Concanavalin A / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D003609:Dactinomycin / Q000494:pharmacology*; D004357:Drug Synergism; D006023:Glycoproteins / Q000494:pharmacology; D008297:Male; D051379:Mice; D009163:Mycobacterium bovis / Q000276:immunology; D010844:Picibanil / Q000494:pharmacology*; D011070:Poly I-C / Q000494:pharmacology*; D011135:Polysaccharides, Bacterial / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha
D001688:Biological Products; D006023:Glycoproteins; D011135:Polysaccharides, Bacterial; D014409:Tumor Necrosis Factor-alpha; D003208:Concanavalin A; D003609:Dactinomycin; D010844:Picibanil; D011070:Poly I-C